Multiple points of intervention in the prevention of cancer and other mutation-related diseases

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 480-481, Issue , 2001, Pages 9-22

  Flora, Silvio De ^a   Izzotti, Alberto ^a   D'Agostini, Francesco ^a   Balansky, Roumen M ^b   Noonan, Douglas ^c   Albini, Adriana ^c  

^a UNIVERSITY OF GENOA   (Italy)

^b National Oncology Center Bulgaria   (Bulgaria)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Cancer; Chemoprevention; Mechanisms; Mutation related diseases; Prevention

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; BETA NAPHTHOFLAVONE; CALCIUM; CATHEPSIN; CELL ADHESION MOLECULE; CHLOROPHYLL; COLECALCIFEROL; DOXORUBICIN; FLAVONOID; GLUTATHIONE; HEMIN; INDOLE DERIVATIVE; ISOTHIOCYANIC ACID DERIVATIVE; METALLOPROTEINASE; NONSTEROID ANTIINFLAMMATORY AGENT; OLTIPRAZ; PHENETHYL ISOTHIOCYANATE; PHENOL DERIVATIVE; PRASTERONE; PROTEINASE INHIBITOR; RETINOL; SELENIUM DERIVATIVE; SERINE PROTEINASE; TAMOXIFEN; TISSUE INHIBITOR OF METALLOPROTEINASE; UNINDEXED DRUG; UVOMORULIN;

ANGIOGENESIS; APOPTOSIS; ARTERY MUSCLE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CANCER INVASION; CANCER PREVENTION; CANCER RECURRENCE; CANCER STAGING; CARDIOVASCULAR RISK; CELL ADHESION; CHEMOPROPHYLAXIS; DIET; DNA ADDUCT; DRUG EFFICACY; DRUG MECHANISM; EARLY DIAGNOSIS; GENE MUTATION; GENOTOXICITY; GENOTYPE; HUMAN; METASTASIS; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER;

EID: 0035451079     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(01)00165-8     Document Type: Article

References (59)

1. DNA adducts in chronic degenerative diseases: Pathogenetic relevance and implications in preventive medicine
2. DNA alterations in rat organs following chronic exposure to cigarette smoke and/or ethanol ingestion
3. Molecular epidemiology of atherosclerosis
4. Increased DNA alterations in atherosclerotic lesions of individuals lacking the GSTM1 genotype
5. Induction by carcinogens and chemoprevention by N-acetylcysteine of adducts to mitochondrial DNA in rat organs
6. Scope and methods of prevention
7. Progress in cancer chemoprevention: Perspectives on agent selection and short-term clinical intervention trials
8. Experimental databases on inhibition of the bacterial mutagenicity of 4-nitroquinoline-1-oxide and cigarette smoke
9. Structural basis of antimutagenicity towards 4-nitroquinoline-1-oxide
10. Assessment of Antimutagenicity and Anticarcinogenicity, End-Points and Systems
11. Apoptosis in the pathogenesis and treatment of disease
12. Mechanisms of inhibitors of mutagenesis and carcinogenesis
13. Modulation of apoptosis by cigarette smoke and chemopreventive agents in the respiratory tract of rats
14. Modulation of biomarkers by chemopreventive agents in smoke-exposed rats
15. Inhibition by N-acetylcysteine of carcinogen-DNA adducts in the tracheal epithelium of rats exposed to cigarette smoke
16. Inhibitors of chemical carcinogenesis
17. Environmental desmutagens and antimutagens
18. Inhibitors of mutagenesis and their relevance to carcinogenesis
19. Mechanisms of inhibitors of mutagenesis and carcinogenesis: Classifiction and overview
20. Mechanistic considerations in the evaluation of chemopreventive data
21. Chemoprotection against cancer by phase II enzyme induction
22. Metabolism of chemical carcinogens
23. Patterns of DNA adduct formation in liver and mammary epithelial cells of rats treated with 7,12-dimethylbenz(a) anthracene, and selective effects of chemopreventive agents
24. Rationale and mechanisms of cancer chemoprevention
25. Cancer chemopreventive agents: Drug development status and future prospects
26. Interactions between N-acetylcysteine and ascorbic acid in modulating mutagenesis and carcinogenesis
27. On the antioxidant effects of ascorbic acid and glutathione
28. Mechanisms of anticarcinogenesis: The example of N-acetylcysteine
29. Chemoprevention by OPZ and other dithiolthiones
30. Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points
31. Tumor progression and metastasis
32. General mechanisms of metastasis
33. Extracellular regulation of cancer invasion: The E-cadherin-catenin and other pathways
34. Integrin signaling
35. The alpha3beta1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity
36. CD44 glycoproteins in colorectal cancer: Expression, function, and prognostic value
37. Matrix metalloproteinases: Multifunctional contributors to tumor progression
38. uPA, uPAR, PAI-1: Key intersection of proteolytic, adhesive and chemotactic highways?
39. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
40. Inhibition of tumor cell invasion by a highly conserved peptide sequence from the matrix metalloproteinase enzyme prosegment
41. Tumor cell invasion inhibited by TIMP-2
42. TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis
43. Tissue inhibitor of metalloproteinase (TIMP)-1 induces differentiation and an antiapoptotic phenotype in germinal center B cells
44. Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3
45. Matrix metalloproteinase inhibition as a novel anticancer strategy: A review with special focus on batimastat and marimastat
46. Angiogenesis in cancer, vascular, rheumatoid and other disease
47. Angiogenesis at the interface between basic and clinical research
48. Inhibition of invasion, gelatinase activity, tumor take and metastasis of malignant cells by N-acetylcysteine
49. Synergism between N-acetylcysteine and doxorubicin in the prevention of tumorigenicity and metastasis in murine models
50. Inhibition by oral N-acetylcysteine of doxorubicin-induced clastogenicity and alopecia, and prevention of primary tumors and lung micrometastases in mice
51. The role of the thiol N-acetylcysteine in the prevention of tumor invasion and angiogenesis
52. N-acetylcysteine inhibits endothelial cell invasion and angiogenesis
53. Retinoids as antitumor agents: A new age of biological therapy
54. Retinoids in chemoprevention and differentiation therapy
55. Retinoic acid negatively regulates b4 integrin expression and suppresses the malignant phenotype in a Lewis lung carcinoma cell line
56. Tea and tea polyphenols inhibit cell hyperproliferation, lung tumorigenesis, and tumor progression
57. Tumor invasion: Molecular shears blunted by green tea
58. Angiogenesis inhibited by drinking tea
59. Adducts to nuclear DNA and mitochondrial DNA as biomarkers in chemoprevention